Our results showed that ITGA3 had a negative correlation with B cell markers (CD19 and CD79a), suggesting that the low expression of ITGA3 in BRCA might promote B cell infiltration and lead to immunosuppression. This evidence concerns the gene CD79A and invasive breast carcinoma.